Zebrafish model in drug safety assessment

Current Pharmaceutical Design

Volumn 20, Issue 34, 2014, Pages 5416-5429

  Kanungo, Jyotshna ^a   Cuevas, Elvis ^a   Ali, Syed F ^a   Paule, Merle G ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Cardiotoxicity; Drug; Hepatotoxicity; High throughput assay; Neurotoxicity; Toxicity screening; Zebrafish

Indexed keywords

ARTICLE; CARDIOTOXICITY; DEVELOPMENTAL BIOLOGY; DEVELOPMENTAL GENETICS; DRUG SAFETY; EXPLANT; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; LARVA; LIVER TOXICITY; MICROINJECTION; MORPHOLOGY; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; TERATOLOGY; TOXICITY ASSAY; ZEBRA FISH; ANIMAL; ANIMAL MODEL; DRUG EFFECTS; DRUG SCREENING; EMBRYO DEVELOPMENT; PHYSIOLOGY; PROCEDURES; TOXICITY TESTING;

TERATOGENIC AGENT;

ANIMALS; DRUG EVALUATION, PRECLINICAL; EMBRYONIC DEVELOPMENT; HUMANS; MODELS, ANIMAL; TERATOGENS; TOXICITY TESTS; ZEBRAFISH;

EID: 84921862955     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140205145658     Document Type: Article

References (268)

1. [1] Stevens JL, Baker TK. The future of drug safety testing: expanding the view and narrowing the focus. Drug Discov Today 20 2009; 14: 162-7.
2. [2] Spielmann H, Grune B, Liebsch M, Seiler A, Vogel R. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment). Exp Toxicol Pathol 2008; 60: 225-33.
3. [3] Hofer T, Gerner I, Gundert-Remy U, et al. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation. Arch Toxicol 2004; 78: 549-64.
4. [4] Brittijn SA, Duivesteijn SJ, Belmamoune M, et al. Zebrafish development and regeneration: new tools for biomedical research. Int J Dev Biol 2009; 53: 835-50.
5. [5] Hill AJ, Teraoka H, Heideman W, Peterson RE. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005; 86: 6-19.
6. [6] Kari G, Rodeck U, Dicker AP. Zebrafish: an emerging model system for human disease and drug discovery. Clin Pharmacol Ther 2007; 82: 70-80.
7. [7] Parng C, Roy NM, Ton C, Lin Y, McGrath P. Neurotoxicity assessment using zebrafish. J Pharmacol Toxicol Methods 2007; 55: 103-12.
8. [8] Reimers MJ, La Du JK, Periera CB, Giovanini J, Tanguay RL. Ethanol-dependent toxicity in zebrafish is partially attenuated by antioxidants. Neurotoxicol Teratol 2006; 28: 497-508.
9. Spitsbergen JM, Kent ML. The state of the art of the zebrafish model for toxicology and toxicologic pathology research-advantages and current limitations. Toxicol Pathol 2003; 31 Suppl: 62-87.
10. [10] Teraoka H, Dong W, Tsujimoto Y, et al. Induction of cytochrome P450 1A is required for circulation failure and edema by 2,3,7,8-tetrachlorodibenzo-p-dioxin in zebrafish. Biochem Biophys Res Commun 2003; 304: 223-8.
11. [11] Van den Belt K, Van Puymbroeck S, Witters H. Toxicity of cadmium-contaminated clay to the zebrafish Danio rerio. Arch Environ Contam Toxicol 2000; 38: 191-6.
12. [12] Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005; 4: 35-44.
13. [13] Strahle U, Scholz S, Geisler R, et al. Zebrafish embryos as an alternative to animal experiments--a commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod Toxicol 2012; 33: 128-32.
14. [14] Knudsen T, Martin M, Chandler K, Kleinstreuer N, Judson R, Sipes N. Predictive models and computational toxicology. Methods Mol Biol 2013; 947: 343-74.
15. [15] Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet 2007; 8: 353-67.
16. [16] Peterson RT, Macrae CA. Systematic approaches to toxicology in the zebrafish. Annu Rev Pharmacol Toxicol 2012; 52: 433-53.
17. [17] Selderslaghs IW, Van Rompay AR, De Coen W, Witters HE. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod Toxicol 2009; 28: 308-20.
18. [18] Stainier DY, Fishman MC. The zebrafish as a model system to study cardiovascular development. Trends Cardiovasc Med 1994; 4: 207-12.
19. [19] Howe K, Clark MD, Torroja CF, et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013; 496: 498-503.
20. [20] Kettleborough RN, Busch-Nentwich EM, et al. A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature 2013; 496: 494-7.
21. [21] Granato M, Nusslein-Volhard C. Fishing for genes controlling development. Curr Opin Genet Dev 1996; 6: 461-8.
22. [22] Postlethwait JH, Woods IG, Ngo-Hazelett P, et al. Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res 2000; 10: 1890-902.
23. [23] Lam KH, Alex D, Lam IK, Tsui SK, Yang ZF, Lee SM. Nobiletin, a polymethoxylated flavonoid from citrus, shows anti-angiogenic activity in a zebrafish in vivo model and HUVEC in vitro model. J Cell Biochem 2011; 112: 3313-21.
24. [24] Stein C, Caccamo M, Laird G, Leptin M. Conservation and divergence of gene families encoding components of innate immune response systems in zebrafish. Genome Biol 2007; 8: R251.
25. [25] Zimmerman AM, Romanowski KE, Maddox BJ. Targeted annotation of immunoglobulin light chain (IgL) genes in zebrafish from BAC clones reveals kappa-like recombining/deleting elements within IgL constant regions. Fish Shellfish Immunol 2011; 31: 697-703.
26. [26] MacRae CA, Peterson RT. Zebrafish-based small molecule discovery. Chem Biol 2003; 10: 901-8.
27. [27] Goldsmith P. Zebrafish as a pharmacological tool: the how, why and when. Curr Opin Pharmacol 2004; 4: 504-12.
28. [28] Bretaud S, Lee S, Guo S. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol Teratol 2004; 26: 857-64.
29. [29] Gibbs EM, Horstick EJ, Dowling JJ. Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies. FEBS J 2013.
30. [30] Parng C. In vivo zebrafish assays for toxicity testing. Curr Opin Drug Discov Devel 2005; 8: 100-6.
31. [31] Rubinstein AL. Zebrafish assays for drug toxicity screening. Expert Opin Drug Metab Toxicol 2006; 2: 231-40.
32. [32] Drapeau P, Saint-Amant L, Buss RR, Chong M, McDearmid JR, Brustein E. Development of the locomotor network in zebrafish. Prog Neurobiol 2002; 68: 85-111.
33. [33] Best JD, Alderton WK. Zebrafish: An in vivo model for the study of neurological diseases. Neuropsychiatr Dis Treat 2008; 4: 567-76.
34. [34] Best JD, Berghmans S, Hunt JJ, Clarke SC, Fleming A, Goldsmith P, Roach AG. Non-associative learning in larval zebrafish. Neuropsychopharmacology 2008; 33: 1206-15.
35. [35] Emran F, Rihel J, Dowling JE. A behavioral assay to measure responsiveness of zebrafish to changes in light intensities. J Vis Exp 2008.
36. [36] Guo S. Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish? Genes Brain Behav 2004; 3: 63-74.
37. [37] Guo S. Using zebrafish to assess the impact of drugs on neural development and function. Expert Opin Drug Discov 2009; 4: 715-726.
38. [38] Irons TD, MacPhail RC, Hunter DL, Padilla S. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol 2010; 32: 84-90.
39. [39] Kokel D, Bryan J, Laggner C, et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 2010; 6: 231-237.
40. [40] Kokel D, Peterson RT. Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. Brief Funct Genomic Proteomic 2008; 7: 483-90.
41. [41] Lockwood B, Bjerke S, Kobayashi K, Guo S. Acute effects of alcohol on larval zebrafish: a genetic system for large-scale screening. Pharmacol Biochem Behav 2004; 77: 647-54.
42. [42] Alderton W, Karran E, Ward S. Current and Future Perspectives in Psychiatric Drug Discovery. Drug News Perspect 2009; 22: 360-4.
43. [43] Berghmans S, Hunt J, Roach A, Goldsmith P. Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Res 2007; 75: 18-28.
44. [44] Burgess HA, Granato M. Sensorimotor gating in larval zebrafish. J Neurosci 2007; 27: 4984-94.
45. [45] Gerlai R. High-throughput behavioral screens: the first step towards finding genes involved in vertebrate brain function using zebrafish. Molecules 2010; 15: 2609-22.
46. [46] Muto A, Orger MB, Wehman AM, et al. Forward genetic analysis of visual behavior in zebrafish. PLoS Genet 2005; 1: e66.
47. [47] Rihel J, Prober DA, Arvanites A, et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010; 327: 348-51.
48. [48] Winter MJ, Redfern WS, Hayfield AJ, Owen SF, Valentin JP, Hutchinson TH. Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J Pharmacol Toxicol Methods 2008; 57: 176-87.
49. [49] MacPhail RC, Brooks J, Hunter DL, Padnos B, Irons TD, Padilla S. Locomotion in larval zebrafish: Influence of time of day, lighting and ethanol. Neurotoxicology 2009; 30: 52-8.
50. [50] Richards FM, Alderton WK, Kimber GM, Liu Z, Strang I, Redfern WS, Valentin JP, Winter MJ, Hutchinson TH. Validation of the use of zebrafish larvae in visual safety assessment. J Pharmacol Toxicol Methods 2008; 58: 50-8.
51. [51] Airhart MJ, Lee DH, Wilson TD, Miller BE, Miller MN, Skalko RG. Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). Neurotoxicol Teratol 2007; 29: 652-64.
52. [52] Boehmler W, Petko J, Woll M, et al. Identification of zebrafish A2 adenosine receptors and expression in developing embryos. Gene Expr Patterns 2009; 9: 144-51.
53. [53] Zhdanova IV, Wang SY, Leclair OU, Danilova NP. Melatonin promotes sleep-like state in zebrafish. Brain Res 2001; 903: 263-8.
54. [54] Cahill GM. Clock mechanisms in zebrafish. Cell Tissue Res 2002; 309: 27-34.
55. [55] Ninkovic J, Bally-Cuif L. The zebrafish as a model system for assessing the reinforcing properties of drugs of abuse. Methods 2006; 39: 262-74.
56. [56] Orger MB, Gahtan E, Muto A, Page-McCaw P, Smear MC, Baier H. Behavioral screening assays in zebrafish. Methods Cell Biol 2004; 77: 53-68.
57. [57] Padilla S, Corum D, Padnos B, et al. Zebrafish developmental screening of the ToxCast Phase I chemical library. Reprod Toxicol 2012; 33: 174-87.
58. [58] Baraban SC, Taylor MR, Castro PA, Baier H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 2005; 131: 759-68.
59. [59] Tiedeken JA, Ramsdell JS. Embryonic exposure to domoic Acid increases the susceptibility of zebrafish larvae to the chemical convulsant pentylenetetrazole. Environ Health Perspect 2007; 115: 1547-52.
60. [60] Baxendale S, Holdsworth CJ, Meza Santoscoy PL, et al. Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures. Dis Model Mech 2012; 5: 773-84.
61. [61] Carvan MJ, III, Loucks E, Weber DN, Williams FE. Ethanol effects on the developing zebrafish: neurobehavior and skeletal morphogenesis. Neurotoxicol Teratol 2004; 26: 757-68.
62. [62] Delvecchio C, Tiefenbach J, Krause HM. The zebrafish: a powerful platform for in vivo, HTS drug discovery. Assay Drug Dev Technol 2011; 9: 354-61.
63. [63] Xia T, Zhao Y, Sager T, et al. Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano 2011; 5: 1223-35.
64. [64] Bai W, Tian W, Zhang Z, et al. Effects of copper nanoparticles on the development of zebrafish embryos. J Nanosci Nanotechnol 2010; 10: 8670-6.
65. [65] Chen YH, Tsai IT, Wen CC, Wang YH, Cheng CC, Hu SC. Fin reduction is a novel and unexpected teratogenic effect of amikacintreated zebrafish embryos. Toxicol Mech Methods 2012; 22: 151-8.
66. [66] Cheng J, Cheng SH. Influence of carbon nanotube length on toxicity to zebrafish embryos. Int J Nanomedicine 2012; 7: 3731-9.
67. [67] King Heiden TC, Spitsbergen J, Heideman W, Peterson RE. Persistent adverse effects on health and reproduction caused by exposure of zebrafish to 2,3,7,8-tetrachlorodibenzo-p-dioxin during early development and gonad differentiation. Toxicol Sci 2009; 109: 75-87.
68. [68] King-Heiden TC, Wiecinski PN, Mangham AN, et al. Quantum dot nanotoxicity assessment using the zebrafish embryo. Environ Sci Technol 2009; 43: 1605-11.
69. [69] Lee KJ, Browning LM, Nallathamby PD, Desai T, Cherukuri PK, Xu XH. In vivo quantitative study of sized-dependent transport and toxicity of single silver nanoparticles using zebrafish embryos. Chem Res Toxicol 2012; 25: 1029-46.
70. [70] Truong L, Harper SL, Tanguay RL. Evaluation of embryotoxicity using the zebrafish model. Methods Mol Biol 2011; 691: 271-9.
71. [71] Usenko CY, Hopkins DC, Trumble SJ, Bruce ED. Hydroxylated PBDEs induce developmental arrest in zebrafish. Toxicol Appl Pharmacol 2012; 262: 43-51.
72. [72] Usenko CY, Robinson EM, Usenko S, Brooks BW, Bruce ED. PBDE developmental effects on embryonic zebrafish. Environ Toxicol Chem 2011; 30: 1865-72.
73. [73] Zhu X, Tian S, Cai Z. Toxicity assessment of iron oxide nanoparticles in zebrafish (Danio rerio) early life stages. PLoS One 2012; 7: e46286.
74. [74] Zhu X, Zhu L, Duan Z, Qi R, Li Y, Lang Y. Comparative toxicity of several metal oxide nanoparticle aqueous suspensions to Zebrafish (Danio rerio) early developmental stage. J Environ Sci Health A Tox Hazard Subst Environ Eng 2008; 43: 278-84.
75. [75] Zhu X, Zhu L, Li Y, Duan Z, Chen W, Alvarez PJ. Developmental toxicity in zebrafish (Danio rerio) embryos after exposure to manufactured nanomaterials: buckminsterfullerene aggregates (nC60) and fullerol. Environ Toxicol Chem 2007; 26: 976-9.
76. [76] Oliveira R, Domingues I, Koppe Grisolia C, Soares AM. Effects of triclosan on zebrafish early-life stages and adults. Environ Sci Pollut Res Int 2009; 16: 679-88.
77. [77] Van den Bulck K, Hill A, Mesens N, Diekman H, De Schaepdrijver L, Lammens L. Zebrafish developmental toxicity assay: A fishy solution to reproductive toxicity screening, or just a red herring? Reprod Toxicol 2011; 32: 213-9.
78. [78] Ton C, Lin Y, Willett C. Zebrafish as a model for developmental neurotoxicity testing. Birth Defects Res A Clin Mol Teratol 2006; 76: 553-67.
79. [79] Tamplin OJ, White RM, Jing L, et al. Small molecule screening in zebrafish: swimming in potential drug therapies. Wiley Interdiscip Rev Dev Biol 2012; 1: 459-68.
80. [80] Peters PW, Piersma AH. In vitro embryotoxicity and teratogenicity studies. Toxicol In vitro 1990; 4: 570-6.
81. [81] Dawson DA, Fort DJ, Smith GJ, Newell DL, Bantle JA. Evaluation of the developmental toxicity of nicotine and cotinine with frog embryo teratogenesis assay: Xenopus. Teratog Carcinog Mutagen 1988; 8: 329-38.
82. [82] Bantle JA, Fort DJ, Rayburn JR, DeYoung DJ, Bush SJ. Further validation of FETAX: evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens. Drug Chem Toxicol 1990; 13: 267-82.
83. [83] Fort DJ, Bantle JA. Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin. Fundam Appl Toxicol 1990; 14: 720-33.
84. [84] Fort DJ, Bantle JA. Analysis of the mechanism of isoniazidinduced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX). Teratog Carcinog Mutagen 1990; 10: 463-76.
85. [85] Bernauer U, Oberemm A, Madle S, Gundert-Remy U. The use of in vitro data in risk assessment. Basic Clin Pharmacol Toxicol 2005; 96: 176-81.
86. [86] Fort DJ, Dawson DA, Bantle JA. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX). Teratog Carcinog Mutagen 1988; 8: 251-63.
87. [87] Martin MT, Judson RS, Reif DM, Kavlock RJ, Dix DJ. Profiling chemicals based on chronic toxicity results from the U.S. EPA ToxRef Database. Environ Health Perspect 2009; 117: 392-9.
88. [88] McGrath P, Li CQ. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today 2008; 13: 394-401.
89. [89] Brannen KC, Charlap JH, Lewis EM. Zebrafish teratogenicity testing. Methods Mol Biol 2013; 947: 383-401.
90. [90] Brannen KC, Panzica-Kelly JM, Danberry TL, Augustine-Rauch KA. Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. Birth Defects Res B Dev Reprod Toxicol 2010; 89: 66-77.
91. [91] Panzica-Kelly JM, Zhang CX, Augustine-Rauch K. Zebrafish embryo developmental toxicology assay. Methods Mol Biol 2012; 889: 25-50.
92. [92] Hermsen SA, van den Brandhof EJ, van der Ven LT, Piersma AH. Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies. Toxicol In vitro 2011; 25: 745-53.
93. [93] Sipes NS, Padilla S, Knudsen TB. Zebrafish: as an integrative model for twenty-first century toxicity testing. Birth Defects Res C Embryo Today 2011; 93: 256-67.
94. [94] Gustafson AL, Stedman DB, Ball J, et al. Inter-laboratory assessment of a harmonized zebrafish developmental toxicology assay-progress report on phase I. Reprod Toxicol 2012; 33: 155-64.
95. [95] Hermsen SA, Pronk TE, van den Brandhof EJ, van der Ven LT, Piersma AH. Chemical class-specific gene expression changes in the zebrafish embryo after exposure to glycol ether alkoxy acids and 1,2,4-triazole antifungals. Reprod Toxicol 2011; 32: 245-52.
96. [96] McCollum CW, Ducharme NA, Bondesson M, Gustafsson JA. Developmental toxicity screening in zebrafish. Birth Defects Res C Embryo Today 2011; 93: 67-114.
97. [97] Selderslaghs IW, Blust R, Witters HE. Feasibility study of the zebrafish assay as an alternative method to screen for developmental toxicity and embryotoxicity using a training set of 27 compounds. Reprod Toxicol 2012; 33: 142-54.
98. [98] Scholz S. Zebrafish embryos as an alternative model for screening of drug-induced organ toxicity. Arch Toxicol 2013; 87: 767-9.
99. [99] Berghmans S, Butler P, Goldsmith P, et al. Zebrafish based assays for the assessment of cardiac, visual and gut function--potential safety screens for early drug discovery. J Pharmacol Toxicol Methods 2008; 58: 59-68.
100. [100] Eimon PM, Rubinstein AL. The use of in vivo zebrafish assays in drug toxicity screening. Expert Opin Drug Metab Toxicol 2009; 5: 393-401.
101. [101] MacRae CA. Recent advances in in vivo screening for antiarrhythmic drugs. Expert Opin Drug Discov 2013; 8: 131-41.
102. [102] Parng C, Seng WL, Semino C, McGrath P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 2002; 1: 41-8.
103. [103] Langheinrich U, Vacun G, Wagner T. Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QTprolonging drugs inducing severe arrhythmia. Toxicol Appl Pharmacol 2003; 193: 370-82.
104. [104] Thisse C, Zon LI. Organogenesis--heart and blood formation from the zebrafish point of view. Science 2002; 295: 457-62.
105. [105] Zheng W, Wang Z, Collins JE, Andrews RM, Stemple D, Gong Z. Comparative transcriptome analyses indicate molecular homology of zebrafish swimbladder and mammalian lung. PLoS One 2011; 6: e24019.
106. [106] Hassel D, Scholz EP, Trano N, et al. Deficient zebrafish ether-ago-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants. Circulation 2008; 117: 866-75.
107. [107] George S, Xia T, Rallo R, et al. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano 2011; 5: 1805-17.
108. [108] Mittelstadt SW, Hemenway CL, Craig MP, Hove JR. Evaluation of zebrafish embryos as a model for assessing inhibition of hERG. J Pharmacol Toxicol Methods 2008; 57: 100-5.
109. [109] Langheinrich U. Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 2003; 25: 904-12.
110. [110] Craig MP, Gilday SD, Hove JR. Dose-dependent effects of chemical immobilization on the heart rate of embryonic zebrafish. Lab Anim (NY) 2006; 35: 41-7.
111. [111] Forouhar AS, Hove JR, Calvert C, Flores J, Jadvar H, Gharib M. Electrocardiographic characterization of embryonic zebrafish. Conf Proc IEEE Eng Med Biol Soc 2004; 5: 3615-7.
112. [112] Chi NC, Shaw RM, Jungblut B, et al. Genetic and physiologic dissection of the vertebrate cardiac conduction system. PLoS Biol 2008; 6: e109.
113. [113] Chi NC, Bussen M, Brand-Arzamendi K, et al. Cardiac conduction is required to preserve cardiac chamber morphology. Proc Natl Acad Sci USA 2010; 107: 14662-7.
114. [114] Kanungo J, Cuevas E, Ali SF, Paule MG. l-Carnitine rescues ketamine-induced attenuated heart rate and MAPK (ERK) activity in zebrafish embryos. Reprod Toxicol 2012; 33: 205-12.
115. [115] Milan DJ, Jones IL, Ellinor PT, MacRae CA. In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol 2006; 291: H269-73.
116. [116] Milan DJ, Macrae CA. Zebrafish genetic models for arrhythmia. Prog Biophys Mol Biol 2008; 98: 301-8.
117. [117] Milan DJ, Peterson TA, Ruskin JN, Peterson RT, MacRae CA. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 2003; 107: 1355-8.
118. [118] Sedmera D, Reckova M, de Almeida A, et al. Functional and morphological evidence for a ventricular conduction system in zebrafish and Xenopus hearts. Am J Physiol Heart Circ Physiol 2003; 284: H1152-60.
119. [119] Carney SA, Peterson RE, Heideman W. 2,3,7,8-Tetrachlorodibenzo-p-dioxin activation of the aryl hydrocarbon receptor/ aryl hydrocarbon receptor nuclear translocator pathway causes developmental toxicity through a CYP1A-independent mechanism in zebrafish. Mol Pharmacol 2004; 66: 512-21.
120. [120] Wiegand C, Pflugmacher S, Giese M, Frank H, Steinberg C. Uptake, toxicity, and effects on detoxication enzymes of atrazine and trifluoroacetate in embryos of zebrafish. Ecotoxicol Environ Saf 2000; 45: 122-31.
121. [121] Ibabe A, Grabenbauer M, Baumgart E, Fahimi HD, Cajaraville MP. Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio). Histochem Cell Biol 2002; 118: 231-9.
122. Zhang C, Willett C, Fremgen T. Zebrafish: an animal model for toxicological studies. Curr Protoc Toxicol 2003; Chapter 1: Unit1 7.
123. [123] He JH, Guo SY, Zhu F, et al. A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity. J Pharmacol Toxicol Methods 2013; 67: 25-32.
124. [124] Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006; 6: 947-60.
125. [125] Nebert DW, Nelson DR, Coon MJ, et al. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol 1991; 10: 1-14.
126. [126] Zhang YY, Yang L. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications. Expert Opin Drug Metab Toxicol 2009; 5: 621-9.
127. [127] Goldstone JV, McArthur AG, Kubota A, et al. Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish. BMC Genomics 2010; 11: 643.
128. [128] Simpson ER, Mahendroo MS, Means GD, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 1994; 15: 342-55.
129. [129] Simpson ER, Clyne C, Rubin G, et al. Aromatase--a brief overview. Annu Rev Physiol 2002; 64: 93-127.
130. [130] Cheshenko K, Brion F, Le Page Y, et al. Expression of zebra fish aromatase cyp19a and cyp19b genes in response to the ligands of estrogen receptor and aryl hydrocarbon receptor. Toxicol Sci 2007; 96: 255-67.
131. [131] Tseng HP, Hseu TH, Buhler DR, Wang WD, Hu CH. Constitutive and xenobiotics-induced expression of a novel CYP3A gene from zebrafish larva. Toxicol Appl Pharmacol 2005; 205: 247-58.
132. [132] Pascussi JM, Drocourt L, Fabre JM, Maurel P, Vilarem MJ. Dexamethasone induces pregnane X receptor and retinoid X receptoralpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 2000; 58: 361-72.
133. [133] Scholz S, Fischer S, Gundel U, Kuster E, Luckenbach T, Voelker D. The zebrafish embryo model in environmental risk assessment--applications beyond acute toxicity testing. Environ Sci Pollut Res Int 2008; 15: 394-404.
134. [134] Segner H. Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption. Comp Biochem Physiol C Toxicol Pharmacol 2009; 149: 187-95.
135. [135] Scholz S, Mayer I. Molecular biomarkers of endocrine disruption in small model fish. Mol Cell Endocrinol 2008; 293: 57-70.
136. [136] Tropepe V, Sive HL. Can zebrafish be used as a model to study the neurodevelopmental causes of autism? Genes Brain Behav 2003; 2: 268-81.
137. [137] Mueller T, Vernier P, Wullimann MF. The adult central nervous cholinergic system of a neurogenetic model animal, the zebrafish Danio rerio. Brain Res 2004; 1011: 156-69.
138. [138] Rink E, Wullimann MF. Connections of the ventral telencephalon (subpallium) in the zebrafish (Danio rerio). Brain Res 2004; 1011: 206-20.
139. [139] Wullimann MF, Mueller T. Identification and morphogenesis of the eminentia thalami in the zebrafish. J Comp Neurol 2004; 471: 37-48.
140. [140] Jeong JY, Kwon HB, Ahn JC, et al. Functional and developmental analysis of the blood-brain barrier in zebrafish. Brain Res Bull 2008; 75: 619-28.
141. [141] Xie J, Farage E, Sugimoto M, Anand-Apte B. A novel transgenic zebrafish model for blood-brain and blood-retinal barrier development. BMC Dev Biol 2010; 10: 76.
142. [142] Watanabe K, Nishimura Y, Nomoto T, et al. In vivo assessment of the permeability of the blood-brain barrier and blood-retinal barrier to fluorescent indoline derivatives in zebrafish. BMC Neurosci 2012; 13: 101.
143. [143] O'Callaghan JP, Sriram K. Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opin Drug Saf 2005; 4: 433-42.
144. [144] de Esch C, Slieker R, Wolterbeek A, Woutersen R, de Groot D. Zebrafish as potential model for developmental neurotoxicity testing: a mini review. Neurotoxicol Teratol 2012; 34: 545-53.
145. [145] Appel B, Chitnis A. Neurogenesis and specification of neuronal identity. Results Probl Cell Differ 2002; 40: 237-51.
146. [146] Mueller T, Wullimann MF. Anatomy of neurogenesis in the early zebrafish brain. Brain Res Dev Brain Res 2003; 140: 137-55.
147. [147] Hill A, Howard CV, Strahle U, Cossins A. Neurodevelopmental defects in zebrafish (Danio rerio) at environmentally relevant dioxin (TCDD) concentrations. Toxicol Sci 2003; 76: 392-9.
148. [148] Kanungo J, Cuevas E, Ali SF, Paule MG. Ketamine induces motor neuron toxicity and alters neurogenic and proneural gene expression in zebrafish. J Appl Toxicol 2011.
149. Cuevas E, Trickler WJ, Guo X, Ali SF, Paule MG, Kanungo J. Acetyl l-carnitine protects motor neurons and Rohon-Beard sensory neurons against ketamine-induced neurotoxicity in zebrafish embryos. Neurotoxicology and Teratology.
150. [150] Parng C, Ton C, Lin YX, Roy NM, McGrath P. A zebrafish assay for identifying neuroprotectants in vivo. Neurotoxicol Teratol 2006; 28: 509-16.
151. [151] Ali DW, Buss RR, Drapeau P. Properties of miniature glutamatergic EPSCs in neurons of the locomotor regions of the developing zebrafish. J Neurophysiol 2000; 83: 181-91.
152. [152] Kanungo J, Cuevas E, Ali SF, Paule MG. Ketamine induces motor neuron toxicity and alters neurogenic and proneural gene expression in zebrafish. J Appl Toxicol 2013; 33: 410-7.
153. [153] Kanungo J, Cuevas E, Guo X, et al. Nicotine alters the expression of molecular markers of endocrine disruption in zebrafish. Neurosci Lett 2012; 526: 133-7.
154. [154] Kanungo J, Paule MG. Disruption of blastomeric F-actin: a potential early biomarker of developmental toxicity in zebrafish. Mol Cell Biochem 2011; 353: 283-90.
155. [155] Legendre P. Pharmacological evidence for two types of postsynaptic glycinergic receptors on the Mauthner cell of 52-h-old zebrafish larvae. J Neurophysiol 1997; 77: 2400-15.
156. [156] Rigo JM, Badiu CI, Legendre P. Heterogeneity of postsynaptic receptor occupancy fluctuations among glycinergic inhibitory synapses in the zebrafish hindbrain. J Physiol 2003; 553: 819-32.
157. [157] Parng C, Anderson N, Ton C, McGrath P. Zebrafish apoptosis assays for drug discovery. Methods Cell Biol 2004; 76: 75-85.
158. [158] Figueroa-Masot XA, Hetman M, Higgins MJ, Kokot N, Xia Z. Taxol induces apoptosis in cortical neurons by a mechanism independent of Bcl-2 phosphorylation. J Neurosci 2001; 21: 4657-67.
159. [159] Svoboda KR, Vijayaraghavan S, Tanguay RL. Nicotinic receptors mediate changes in spinal motoneuron development and axonal pathfinding in embryonic zebrafish exposed to nicotine. J Neurosci 2002; 22: 10731-41.
160. [160] Paule MG, Li M, Allen RR, et al. Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol 2011; 33: 220-30.
161. [161] Slikker W, Jr., Zou X, Hotchkiss CE, et al. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci 2007; 98: 145-58.
162. [162] Wang C, Sadovova N, Fu X, et al. The role of the N-methyl-Daspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience 2005; 132: 967-77.
163. [163] Zou X, Patterson TA, Divine RL, et al. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci 2009; 27: 727-31.
164. [164] Dlugos CA, Rabin RA. Ethanol effects on three strains of zebrafish: model system for genetic investigations. Pharmacol Biochem Behav 2003; 74: 471-80.
165. [165] Gerlai R, Lee V, Blaser R. Effects of acute and chronic ethanol exposure on the behavior of adult zebrafish (Danio rerio). Pharmacol Biochem Behav 2006; 85: 752-61.
166. [166] Mathur P, Berberoglu MA, Guo S. Preference for ethanol in zebrafish following a single exposure. Behav Brain Res 2011; 217: 128-33.
167. [167] Peng J, Wagle M, Mueller T, et al. Ethanol-modulated camouflage response screen in zebrafish uncovers a novel role for cAMP and extracellular signal-regulated kinase signaling in behavioral sensitivity to ethanol. J Neurosci 2009; 29: 8408-18.
168. [168] Loucks E, Ahlgren S. Assessing teratogenic changes in a zebrafish model of fetal alcohol exposure. J Vis Exp 2012.
169. [169] Chromcova L, Stepanova S, Plhalova L, Praskova E, Svobodova Z. Effect of four selected carrier solvents on embryonal stages of Danio rerio. Neuro Endocrinol Lett 2012; 33 Suppl 3: 60-5.
170. [170] Hallare A, Nagel K, Kohler HR, Triebskorn R. Comparative embryotoxicity and proteotoxicity of three carrier solvents to zebrafish (Danio rerio) embryos. Ecotoxicol Environ Saf 2006; 63: 378-88.
171. [171] Reimers MJ, Flockton AR, Tanguay RL. Ethanol-and acetaldehyde-mediated developmental toxicity in zebrafish. Neurotoxicol Teratol 2004; 26: 769-81.
172. [172] Loucks EJ, Ahlgren SC. Deciphering the role of Shh signaling in axial defects produced by ethanol exposure. Birth Defects Res A Clin Mol Teratol 2009; 85: 556-67.
173. [173] Bilotta J, Barnett JA, Hancock L, Saszik S. Ethanol exposure alters zebrafish development: a novel model of fetal alcohol syndrome. Neurotoxicol Teratol 2004; 26: 737-43.
174. [174] Dlugos CA, Rabin RA. Ocular deficits associated with alcohol exposure during zebrafish development. J Comp Neurol 2007; 502: 497-506.
175. [175] Kashyap B, Frederickson LC, Stenkamp DL. Mechanisms for persistent microphthalmia following ethanol exposure during retinal neurogenesis in zebrafish embryos. Vis Neurosci 2007; 24: 409-21.
176. [176] Kashyap B, Frey RA, Stenkamp DL. Ethanol-induced microphthalmia is not mediated by changes in retinoic acid or sonic hedgehog signaling during retinal neurogenesis. Alcohol Clin Exp Res 2011; 35: 1644-61.
177. [177] Matsui JI, Egana AL, Sponholtz TR, Adolph AR, Dowling JE. Effects of ethanol on photoreceptors and visual function in developing zebrafish. Invest Ophthalmol Vis Sci 2006; 47: 4589-97.
178. [178] de Esch C, van der Linde H, Slieker R, et al. Locomotor activity assay in zebrafish larvae: influence of age, strain and ethanol. Neurotoxicol Teratol 2012; 34: 425-33.
179. [179] Loucks E, Carvan MJ, III. Strain-dependent effects of developmental ethanol exposure in zebrafish. Neurotoxicol Teratol 2004; 26: 745-55.
180. [180] Arenzana FJ, Carvan MJ, III, Aijon J, Sanchez-Gonzalez R, Arevalo R, Porteros A. Teratogenic effects of ethanol exposure on zebrafish visual system development. Neurotoxicol Teratol 2006; 28: 342-8.
181. [181] Bilotta J, Saszik S, Givin CM, Hardesty HR, Sutherland SE. Effects of embryonic exposure to ethanol on zebrafish visual function. Neurotoxicol Teratol 2002; 24: 759-66.
182. [182] Blader P, Strahle U. Ethanol impairs migration of the prechordal plate in the zebrafish embryo. Dev Biol 1998; 201: 185-201.
183. [183] Ali S, Champagne DL, Alia A, Richardson MK. Large-scale analysis of acute ethanol exposure in zebrafish development: a critical time window and resilience. PLoS One 2011; 6: e20037.
184. [184] Driscoll CD, Streissguth AP, Riley EP. Prenatal alcohol exposure: comparability of effects in humans and animal models. Neurotoxicol Teratol 1990; 12: 231-7.
185. [185] Cudd TA. Animal model systems for the study of alcohol teratology. Exp Biol Med (Maywood) 2005; 230: 389-93.
186. [186] Sylvain NJ, Brewster DL, Ali DW. Embryonic ethanol exposure alters synaptic properties at zebrafish neuromuscular junctions. Neurotoxicol Teratol 2011; 33: 313-21.
187. [187] Sylvain NJ, Brewster DL, Ali DW. Zebrafish embryos exposed to alcohol undergo abnormal development of motor neurons and muscle fibers. Neurotoxicol Teratol 2010; 32: 472-80.
188. [188] Kanungo J, Lantz S, Paule MG. In vivo imaging and quantitative analysis of changes in axon length using transgenic zebrafish embryos. Neurotoxicol Teratol 2011; 33: 618-23.
189. [189] Jacobs JS, Miller MW. Proliferation and death of cultured fetal neocortical neurons: effects of ethanol on the dynamics of cell growth. J Neurocytol 2001; 30: 391-401.
190. [190] Fleisch VC, Neuhauss SC. Visual behavior in zebrafish. Zebrafish 2006; 3: 191-201.
191. [191] Neuhauss SC, Biehlmaier O, Seeliger MW, et al. Genetic disorders of vision revealed by a behavioral screen of 400 essential loci in zebrafish. J Neurosci 1999; 19: 8603-15.
192. [192] Fekete DM. Developmental biology. Rocks that roll zebrafish. Science 2003; 302: 241-2.
193. [193] Whitfield TT. Zebrafish as a model for hearing and deafness. J Neurobiol 2002; 53: 157-71.
194. [194] Froehlicher M, Liedtke A, Groh KJ, Neuhauss SC, Segner H, Eggen RI. Zebrafish (Danio rerio) neuromast: promising biological endpoint linking developmental and toxicological studies. Aquat Toxicol 2009; 95: 307-19.
195. [195] Metcalfe WK. Sensory neuron growth cones comigrate with posterior lateral line primordial cells in zebrafish. J Comp Neurol 1985; 238: 218-24.
196. [196] Lopez-Schier H, Starr CJ, Kappler JA, Kollmar R, Hudspeth AJ. Directional cell migration establishes the axes of planar polarity in the posterior lateral-line organ of the zebrafish. Dev Cell 2004; 7: 401-12.
197. [197] Froehlicher M, Liedtke A, Groh K, et al. Estrogen receptor subtype beta2 is involved in neuromast development in zebrafish (Danio rerio) larvae. Dev Biol 2009; 330: 32-43.
198. [198] Easter SS, Jr., Nicola GN. The development of vision in the zebrafish (Danio rerio). Dev Biol 1996; 180: 646-63.
199. [199] Zeddies DG, Fay RR. Development of the acoustically evoked behavioral response in zebrafish to pure tones. J Exp Biol 2005; 208: 1363-72.
200. [200] Harris JA, Cheng AG, Cunningham LL, MacDonald G, Raible DW, Rubel EW. Neomycin-induced hair cell death and rapid regeneration in the lateral line of zebrafish (Danio rerio). J Assoc Res Otolaryngol 2003; 4: 219-34.
201. [201] Owens KN, Santos F, Roberts B, et al. Identification of genetic and chemical modulators of zebrafish mechanosensory hair cell death. PLoS Genet 2008; 4: e1000020.
202. [202] Santos F, MacDonald G, Rubel EW, Raible DW. Lateral line hair cell maturation is a determinant of aminoglycoside susceptibility in zebrafish (Danio rerio). Hear Res 2006; 213: 25-33.
203. [203] Ton C, Parng C. The use of zebrafish for assessing ototoxic and otoprotective agents. Hear Res 2005; 208: 79-88.
204. [204] Ou H, Simon JA, Rubel EW, Raible DW. Screening for chemicals that affect hair cell death and survival in the zebrafish lateral line. Hear Res 2012; 288: 58-66.
205. [205] Ou HC, Cunningham LL, Francis SP, et al. Identification of FDAapproved drugs and bioactives that protect hair cells in the zebrafish (Danio rerio) lateral line and mouse (Mus musculus) utricle. J Assoc Res Otolaryngol 2009; 10: 191-203.
206. [206] Uribe PM, Mueller MA, Gleichman JS, et al. Dimethyl sulfoxide (DMSO) exacerbates cisplatin-induced sensory hair cell death in zebrafish (Danio rerio). PLoS One 2013; 8: e55359.
207. [207] Drummond IA, Majumdar A, Hentschel H, et al. Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function. Development 1998; 125: 4655-67.
208. [208] Hentschel DM, Bonventre JV. Novel non-rodent models of kidney disease. Curr Mol Med 2005; 5: 537-46.
209. [209] Hentschel DM, Park KM, Cilenti L, Zervos AS, Drummond I, Bonventre JV. Acute renal failure in zebrafish: a novel system to study a complex disease. Am J Physiol Renal Physiol 2005; 288: F923-9.
210. [210] Kelly M. Chronic renal failure. Am J Nurs 1996; 96: 36-7.
211. [211] Hentschel DM, Mengel M, Boehme L, et al. Rapid screening of glomerular slit diaphragm integrity in larval zebrafish. Am J Physiol Renal Physiol 2007; 293: F1746-50.
212. [212] Pack M, Solnica-Krezel L, Malicki J, et al. Mutations affecting development of zebrafish digestive organs. Development 1996; 123: 321-8.
213. [213] Holmberg A, Schwerte T, Pelster B, Holmgren S. Ontogeny of the gut motility control system in zebrafish Danio rerio embryos and larvae. J Exp Biol 2004; 207: 4085-94.
214. [214] Fleming A, Keynes R, Tannahill D. A central role for the notochord in vertebral patterning. Development 2004; 131: 873-80.
215. [215] Inohaya K, Takano Y, Kudo A. The teleost intervertebral region acts as a growth center of the centrum: in vivo visualization of osteoblasts and their progenitors in transgenic fish. Dev Dyn 2007; 236: 3031-46.
216. [216] Fleming A, Sato M, Goldsmith P. High-throughput in vivo screening for bone anabolic compounds with zebrafish. J Biomol Screen 2005; 10: 823-31.
217. [217] Barrett R, Chappell C, Quick M, Fleming A. A rapid, high content, in vivo model of glucocorticoid-induced osteoporosis. Biotechnol J 2006; 1: 651-5.
218. [218] Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 2009; 5: 1897-910.
219. [219] Grunwald DJ, Streisinger G. Induction of recessive lethal and specific locus mutations in the zebrafish with ethyl nitrosourea. Genet Res 1992; 59: 103-16.
220. [220] Streisinger G, Singer F, Walker C, Knauber D, Dower N. Segregation analyses and gene-centromere distances in zebrafish. Genetics 1986; 112: 311-9.
221. [221] Alestrom P, Holter JL, Nourizadeh-Lillabadi R. Zebrafish in functional genomics and aquatic biomedicine. Trends Biotechnol 2006; 24: 15-21.
222. [222] Driever W, Fishman MC. The zebrafish: heritable disorders in transparent embryos. J Clin Invest 1996; 97: 1788-94.
223. [223] Cui C, Benard EL, Kanwal Z, et al. Infectious disease modeling and innate immune function in zebrafish embryos. Methods Cell Biol 2011; 105: 273-308.
224. [224] Murphey RD, Stern HM, Straub CT, Zon LI. A chemical genetic screen for cell cycle inhibitors in zebrafish embryos. Chem Biol Drug Des 2006; 68: 213-9.
225. [225] Zon LI, Le X. Potential of zebrafish for anticancer drug screening. Expert Opin Drug Discov 2008; 3: 1451-60.
226. [226] Carvalho R, de Sonneville J, Stockhammer OW, et al. A highthroughput screen for tuberculosis progression. PLoS One 2011; 6: e16779.
227. [227] Berger J, Berger S, Hall TE, Lieschke GJ, Currie PD. Dystrophindeficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology. Neuromuscul Disord 2010; 20: 826-32.
228. [228] Berger J, Currie PD. Zebrafish models flex their muscles to shed light on muscular dystrophies. Dis Model Mech 2012; 5: 726-32.
229. [229] Telfer WR, Busta AS, Bonnemann CG, Feldman EL, Dowling JJ. Zebrafish models of collagen VI-related myopathies. Hum Mol Genet 2010; 19: 2433-44.
230. [230] Langenau DM, Keefe MD, Storer NY, et al. Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev 2007; 21: 1382-95.
231. [231] Nasevicius A, Ekker SC. Effective targeted gene 'knockdown' in zebrafish. Nat Genet 2000; 26: 216-20.
232. [232] Wang W, Liu X, Gelinas D, Ciruna B, Sun Y. A fully automated robotic system for microinjection of zebrafish embryos. PLoS One 2007; 2: e862.
233. [233] Hogg RC, Bandelier F, Benoit A, Dosch R, Bertrand D. An automated system for intracellular and intranuclear injection. J Neurosci Methods 2008; 169: 65-75.
234. [234] Veneman WJ, Stockhammer OW, de Boer L, Zaat SA, Meijer AH, Spaink HP. A zebrafish high throughput screening system used for Staphylococcus epidermidis infection marker discovery. BMC Genomics 2013; 14: 255.
235. [235] Noori A, Selvaganapathy PR, Wilson J. Microinjection in a microfluidic format using flexible and compliant channels and electroosmotic dosage control. Lab Chip 2009; 9: 3202-11.
236. [236] Mizell M, Romig ES. The aquatic vertebrate embryo as a sentinel for toxins: zebrafish embryo dechorionation and perivitelline space microinjection. Int J Dev Biol 1997; 41: 411-23.
237. [237] Mathias JR, Saxena MT, Mumm JS. Advances in zebrafish chemical screening technologies. Future Med Chem 2012; 4: 1811-22.
238. [238] Walker SL, Ariga J, Mathias JR, et al. Automated reporter quantification in vivo: high-throughput screening method for reporterbased assays in zebrafish. PLoS One 2012; 7: e29916.
239. [239] Blackburn JS, Liu S, Raimondi AR, Ignatius MS, Salthouse CD, Langenau DM. High-throughput imaging of adult fluorescent zebrafish with an LED fluorescence macroscope. Nat Protoc 2011; 6: 229-41.
240. [240] Burns CG, Milan DJ, Grande EJ, Rottbauer W, MacRae CA, Fishman MC. High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol 2005; 1: 263-4.
241. [241] Gehrig J, Reischl M, Kalmar E, et al. Automated high-throughput mapping of promoter-enhancer interactions in zebrafish embryos. Nat Methods 2009; 6: 911-6.
242. [242] Tran TC, Sneed B, Haider J, et al. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer Res 2007; 67: 11386-92.
243. [243] Vogt A, Cholewinski A, Shen X, et al. Automated image-based phenotypic analysis in zebrafish embryos. Dev Dyn 2009; 238: 656-63.
244. [244] Vogt A, McPherson PA, Shen X, et al. High-content analysis of cancer-cell-specific apoptosis and inhibition of in vivo angiogenesis by synthetic (-)-pironetin and analogs. Chem Biol Drug Des 2009; 74: 358-68.
245. [245] Xu X, Huang X, Xia W, Xia S. A high-throughput analysis method to detect regions of interest and quantify zebrafish embryo images. J Biomol Screen 2010; 15: 1152-9.
246. [246] Chang TY, Pardo-Martin C, Allalou A, Wahlby C, Yanik MF. Fully automated cellular-resolution vertebrate screening platform with parallel animal processing. Lab Chip 2012; 12: 711-6.
247. [247] Radi M, Evensen L, Dreassi E, et al. A combined targeted/ phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: from in silico screening to cyclodextrin formulation. Bioorg Med Chem Lett 2012; 22: 5579-83.
248. [248] Hung MW, Zhang ZJ, Li S, et al. From omics to drug metabolism and high content screen of natural product in zebrafish: a new model for discovery of neuroactive compound. Evid Based Complement Alternat Med 2012; 2012: 605303.
249. [249] Postlethwait J, Amores A, Cresko W, Singer A, Yan YL. Subfunction partitioning, the teleost radiation and the annotation of the human genome. Trends Genet 2004; 20: 481-90.
250. [250] Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N. Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA 2004; 101: 12792-7.
251. [251] Amsterdam A, Sadler KC, Lai K, et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2004; 2: E139.
252. [252] Weigt S, Huebler N, Strecker R, Braunbeck T, Broschard TH. Zebrafish (Danio rerio) embryos as a model for testing proteratogens. Toxicology 2011; 281: 25-36.
253. [253] Martins J, Oliva Teles L, Vasconcelos V. Assays with Daphnia magna and Danio rerio as alert systems in aquatic toxicology. Environ Int 2007; 33: 414-25.
254. [254] de Jong E, Barenys M, Hermsen SA, et al. Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-triazoles. Toxicol Appl Pharmacol 2011; 253: 103-11.
255. [255] Lee HY, Inselman AL, Kanungo J, Hansen DK. Alternative models in developmental toxicology. Syst Biol Reprod Med 2012; 58: 10-22.
256. [256] Halle W. The Registry of Cytotoxicity: toxicity testing in cell cultures to predict acute toxicity (LD50) and to reduce testing in animals. Altern Lab Anim 2003; 31: 89-198.
257. [257] Schreiber R, Altenburger R, Paschke A, Schuurmann G, Kuster E. A novel in vitro system for the determination of bioconcentration factors and the internal dose in zebrafish (Danio rerio) eggs. Chemosphere 2009; 77: 928-33.
258. [258] Trickler WJ, Guo X, Cuevas E, Ali SF, Paule MG, Kanungo J. Ketamine attenuates cytochrome p450 aromatase gene expression and estradiol-17beta levels in zebrafish early life stages. J Appl Toxicol 2013.
259. [259] Kim S, Ji K, Lee S, Lee J, Kim J, Kho Y, Choi K. Perfluorooctane sulfonic acid exposure increases cadmium toxicity in early life stage of zebrafish, Danio rerio. Environ Toxicol Chem 2011; 30: 870-7.
260. [260] Peterson RT, Nass R, Boyd WA, Freedman JH, Dong K, Narahashi T. Use of non-mammalian alternative models for neurotoxicological study. Neurotoxicology 2008; 29: 546-55.
261. [261] Tierney KB. Behavioural assessments of neurotoxic effects and neurodegeneration in zebrafish. Biochim Biophys Acta 2011; 1812: 381-9.
262. [262] Driessen M, Kienhuis AS, Pennings JL, et al. Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxic ity by histopathology and expression profiling. Arch Toxicol 2013; 87: 807-23.
263. [263] Hill A, Mesens N, Steemans M, Xu JJ, Aleo MD. Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development. Drug Metab Rev 2012; 44: 127-40.
264. [264] Ou HC, Santos F, Raible DW, Simon JA, Rubel EW. Drug screening for hearing loss: using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss. Drug Discov Today 2010; 15: 265-71.
265. [265] Coffin AB, Ou H, Owens KN, et al. Chemical screening for hair cell loss and protection in the zebrafish lateral line. Zebrafish 2010; 7: 3-11.
266. [266] Hirose Y, Simon JA, Ou HC. Hair cell toxicity in anti-cancer drugs: evaluating an anti-cancer drug library for independent and synergistic toxic effects on hair cells using the zebrafish lateral line. J Assoc Res Otolaryngol 2011; 12: 719-28.
267. [267] Ali S, Champagne DL, Richardson MK. Behavioral profiling of zebrafish embryos exposed to a panel of 60 water-soluble compounds. Behav Brain Res 2012; 228: 272-83.
268. [268] Bailey J, Oliveri A, Levin ED. Zebrafish model systems for developmental neurobehavioral toxicology. Birth Defects Res C Embryo Today 2013; 99: 14-23.